The Accelerated Drug Approval

被引：12
|
作者：
Novack, Gary D.
机构：
来源：
OCULAR SURFACE | 2010年 / 8卷 / 04期
关键词：
CLINICAL-TRIAL DESIGN; END-POINTS SYMPOSIUM;
D O I：
10.1016/S1542-0124(12)70235-5
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：205 / 206
页数：2
相关论文
共 50 条
  • [1] LYMPHOMA DRUG RECEIVES ACCELERATED APPROVAL
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2011, 111 (11) : 24 - 24
  • [2] Accelerated Drug Approval and Health Inequality
    London, Alex John
    Kimmelman, Jonathan
    JAMA INTERNAL MEDICINE, 2016, 176 (07) : 883 - 884
  • [3] Accelerated drug approval: Meeting the ethical yardstick
    Andreoletti, Mattia
    Blasimme, Alessandro
    BIOETHICS, 2023, 37 (07) : 647 - 655
  • [4] Collateral damage from accelerated drug approval
    Ozaki, Akihiko
    Gonda, Kenji
    Kaneda, Yudai
    Tanimoto, Tetsuya
    NATURE, 2023, 622 (7982) : 242 - 242
  • [5] The FDA Accelerated Drug Approval Program Explained
    Lisi, Donna M.
    US PHARMACIST, 2023, 48 (10) : 46 - 55
  • [6] Accelerated Approval and Oncology Drug Development Timelines
    Lanthier, Michael L.
    Sridhara, Rajeshwari
    Johnson, John R.
    Farrell, Ann
    Keegan, Patricia
    Justice, Robert
    Pazdur, Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (14) : E226 - E227
  • [7] A roadmap for accelerated drug approval in breast cancer?
    Perez-Garcia, Jose
    Cortes, Javier
    LANCET ONCOLOGY, 2012, 13 (09): : 850 - 851
  • [8] Collateral damage from accelerated drug approval
    Akihiko Ozaki
    Kenji Gonda
    Yudai Kaneda
    Tetsuya Tanimoto
    Nature, 2023, 622 : 242 - 242
  • [9] Accelerated Approval and Oncology Drug Development Timelines Reply
    Bennett, Charles L.
    Nebeker, Jonathan R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (14) : E228 - E228
  • [10] ACCELERATED APPROVAL
    NIGHTINGALE, SL
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (24): : 3262 - 3262
12345